Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PsyCan Excoriates Trudeau Government for Making Assisted Suicide Harder than Psychedelic-Assisted Therapy; Calls on Carney and Poilievre to do better
-
Psycan comments on USFDA's recent decision to request a third phase 3 trial prior to approval of
-
Psycan announces that Blue Cross Alberta has issued a notice to prescribers that it will reimburse patients for Psychedelic-Assisted Therapy
-
PsyCan Endorses Senate Report into Psychedelic Treatments for Veterans
-
PsyCan, the trade association for the for-profit psychedelic medicine industry, releases a white paper on how Health Canada can improve access to therapies